Lumibird S.A (LBIRD) | Financial Analysis & Statements
Lumibird S.A. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2024Income Metrics
Balance Sheet Metrics
Total Assets
428.9M
Total Liabilities
222.6M
Shareholders Equity
206.3M
Debt to Equity
1.08
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Lumibird S.A Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 228.5M | 210.1M | 206.6M | 194.3M | 166.4M |
| Cost of Goods Sold | 82.3M | 79.3M | 78.0M | 73.0M | 59.2M |
| Gross Profit | 146.2M | 130.8M | 128.5M | 121.3M | 107.2M |
| Gross Margin % | 64.0% | 62.3% | 62.2% | 62.4% | 64.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | 19.2M |
| Other Operating Expenses | 29.8M | 30.5M | 29.9M | 28.1M | 23.0M |
| Total Operating Expenses | 29.8M | 30.5M | 29.9M | 28.1M | 42.1M |
| Operating Income | 25.6M | 14.9M | 18.4M | 16.3M | 19.7M |
| Operating Margin % | 11.2% | 7.1% | 8.9% | 8.4% | 11.8% |
| Non-Operating Items | |||||
| Interest Income | 1.9M | 1.7M | 1.1M | 126.0K | - |
| Interest Expense | 5.7M | 6.3M | 4.2M | 3.3M | 2.3M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 18.9M | 6.5M | 7.5M | 14.4M | 17.6M |
| Income Tax | 4.9M | 834.0K | 327.0K | 3.1M | 3.7M |
| Effective Tax Rate % | 26.1% | 12.8% | 4.4% | 21.4% | 21.3% |
| Net Income | 14.0M | 5.7M | 7.1M | 11.4M | 13.9M |
| Net Margin % | 6.1% | 2.7% | 3.4% | 5.8% | 8.3% |
| Key Metrics | |||||
| EBITDA | 46.3M | 34.5M | 34.0M | 31.7M | 32.8M |
| EPS (Basic) | - | €0.26 | €0.32 | €0.51 | €0.62 |
| EPS (Diluted) | - | €0.26 | €0.32 | €0.51 | €0.62 |
| Basic Shares Outstanding | - | 22010382 | 22080376 | 22260784 | 22449913 |
| Diluted Shares Outstanding | - | 22010382 | 22080376 | 22260784 | 22449913 |
Income Statement Trend
Lumibird S.A Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 61.6M | 71.1M | 56.2M | 61.7M | 97.1M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 61.1M | 49.4M | 51.6M | 46.6M | 30.5M |
| Inventory | 82.5M | 76.4M | 77.5M | 65.4M | 45.8M |
| Other Current Assets | 1.0K | -1.0K | 1.0K | - | 1.0K |
| Total Current Assets | 216.8M | 208.7M | 197.3M | 187.1M | 182.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 11.8M | 12.0M | 11.3M | 11.4M | 14.1M |
| Goodwill | 208.8M | 214.1M | 203.7M | 193.3M | 187.8M |
| Intangible Assets | 67.3M | 70.0M | 58.5M | 53.4M | 47.3M |
| Long-term Investments | 0 | 0 | 0 | - | - |
| Other Non-Current Assets | - | - | -1.0K | - | - |
| Total Non-Current Assets | 212.0M | 221.1M | 208.0M | 184.9M | 164.8M |
| Total Assets | 428.9M | 429.8M | 405.2M | 372.0M | 347.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 20.9M | 18.0M | 17.6M | 18.1M | 13.2M |
| Short-term Debt | 21.8M | 19.0M | 16.5M | 65.6M | 14.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 15.9M | 15.4M | 15.0M | 13.0M | 3.3M |
| Total Current Liabilities | 87.7M | 79.5M | 74.1M | 119.8M | 57.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 124.4M | 142.0M | 128.6M | 48.6M | 97.9M |
| Deferred Tax Liabilities | 2.9M | 2.8M | 1.9M | 2.6M | 869.0K |
| Other Non-Current Liabilities | 2.0K | -2.0K | 1.0K | 438.0K | 1.0K |
| Total Non-Current Liabilities | 134.9M | 152.3M | 137.8M | 58.8M | 108.4M |
| Total Liabilities | 222.6M | 231.8M | 211.9M | 178.6M | 166.3M |
| Equity | |||||
| Common Stock | 22.5M | 22.5M | 22.5M | 22.5M | 22.5M |
| Retained Earnings | 113.5M | 99.2M | 93.8M | 88.1M | 13.9M |
| Treasury Stock | 7.3M | 7.5M | 6.7M | 3.6M | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 206.3M | 198.0M | 193.3M | 193.4M | 181.3M |
| Key Metrics | |||||
| Total Debt | 146.2M | 161.1M | 145.1M | 114.2M | 112.0M |
| Working Capital | 129.1M | 129.2M | 123.2M | 67.3M | 124.9M |
Balance Sheet Composition
Lumibird S.A Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 14.0M | 5.7M | 7.1M | 11.4M | 13.9M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | 19.8M | 11.7M | 9.8M | 16.0M | 17.4M |
| Investing Activities | |||||
| Capital Expenditures | -16.1M | -22.9M | -25.3M | -20.7M | -18.2M |
| Acquisitions | 0 | -50.0K | -20.6M | -8.1M | -2.1M |
| Investment Purchases | -101.0K | -234.0K | -296.0K | -745.0K | -8.3M |
| Investment Sales | 255.0K | 361.0K | 44.0K | 174.0K | 27.0K |
| Investing Cash Flow | -15.9M | -22.8M | -46.2M | -29.3M | -28.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 12.1M | 81.3M | 50.7M | 15.2M | 38.3M |
| Debt Repayment | -28.6M | -71.9M | -21.9M | -18.8M | -18.1M |
| Financing Cash Flow | -16.6M | 9.4M | 28.7M | -3.6M | 20.4M |
| Free Cash Flow | 12.6M | 11.4M | -4.9M | -28.0M | 6.5M |
| Net Change in Cash | -12.7M | -1.7M | -7.6M | -16.9M | 9.2M |
Cash Flow Trend
Lumibird S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
38.59
Forward P/E
20.84
Price to Book
2.64
Price to Sales
2.38
PEG Ratio
20.84
Profitability Ratios
Profit Margin
6.13%
Operating Margin
13.36%
Return on Equity
6.93%
Return on Assets
3.73%
Financial Health
Current Ratio
2.47
Debt to Equity
70.86
Beta
0.87
Per Share Data
EPS (TTM)
€0.64
Book Value per Share
€9.37
Revenue per Share
€10.38
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LBIRD | 540.6M | 38.59 | 2.64 | 6.93% | 6.13% | 70.86 |
| Eurofins Scientific | 10.8B | 24.24 | 3.08 | 9.50% | 6.51% | 96.84 |
| bioMérieux S.A | 8.4B | 21.24 | 2.04 | 9.54% | 9.77% | 11.24 |
| Eurofins Cerep SAS | 79.7M | 12.94 | - | 8.74% | 15.86% | 0.10 |
| Klea Holding | 54.0M | 17.58 | 1.98 | 9.14% | 11.89% | 18.40 |
| Predilife S.A | 12.2M | - | - | -4,653.75% | 97.76% | -1.15 |
Financial data is updated regularly. All figures are in the company's reporting currency.